Physician profile

Hui-Jin Lee

Periodontics · Broadview Heights, OH

NPI 1811032444

$6,908.43

in general payments reported to CMS, 2019-2025

8 companies · $162 in 2025

The $162 reported for 2025 was more than what a typical Periodontics provider received nationally (typical 2025 total: $111).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$487.30
Gift$97.00
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$27.15

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Straumann USA LLC $6,568.97 2019-2025
Purelife, LLC $100.00 2019
Orapharma, A Division of Bausch Health US, LLC $83.47 2019-2021
Ace Surgical Supply Co., INC. $53.83 2020-2022
Zimmer Biomet Holdings, INC. $50.00 2019
Geistlich Pharma, North America, INC. $28.81 2019
Premier Dental Products Company $13.89 2019
Zest Holdings, LLC $9.46 2022

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Hui-Jin Lee

$6,908.43

in general payments reported 2019-2025

Years
2019-2025
Top company
Straumann USA LLC
Context
The $162 reported for 2025 was more than what a typical Periodontics provider received nationally (typical 2025 total: $111).

https://glasscript.com/doctor/37016/hui-jin-lee

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.